The patient with an intragenic TBX1 deletion (ID 48) presented pulmonary stenosis, primary immunodeficiency, moderate intellectual disability, hypocalcemia, microcephaly, hypermetropia, emotional lability, and facial dysmorphism. This evidence concerns the gene TBX1 and inborn error of immunity.